Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10404)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2014 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He XY, Yuan YZ. Advances in pancreatic cancer research: Moving towards early detection. World J Gastroenterol 2014; 20(32): 11241-11248 [PMID: 25170208 DOI: 10.3748/wjg.v20.i32.11241] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i32/11241.htm |
| Number | Citing Articles |
| 1 |
Sarah Heiler, Zhe Wang, Margot Zöller. Pancreatic cancer stem cell markers and exosomes - the incentive push. World Journal of Gastroenterology 2016; 22(26): 5971-6007 doi: 10.3748/wjg.v22.i26.5971
|
| 2 |
Roseane Guimarães Ferreira, Luis Eduardo Mosquera Narvaez, Kaio Murilo Monteiro Espíndola, Amanda Caroline R. S. Rosario, Wenddy Graziela N. Lima, Marta Chagas Monteiro. Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.594917
|
| 3 |
Bo Wu, Bo-Min Guo, Jie Kang, Xian-Zhao Deng, You-Ben Fan, Xiao-Ping Zhang, Kai-Xing Ai. PPM1D exerts its oncogenic properties in human pancreatic cancer through multiple mechanisms. Apoptosis 2016; 21(3): 365 doi: 10.1007/s10495-015-1211-4
|
| 4 |
Norman Schöffel, Henryk Thielemann. Die Ärztliche Begutachtung. Springer Reference Medizin 2022; : 1 doi: 10.1007/978-3-662-61937-7_69-1
|
| 5 |
Kaiwei Xu, Zhoujian Qiu, Liu Xu, Xuedan Qiu, Lu Hong, Jianhua Wang. Increased Levels of Circulating Circular Rna (Hsa_Circ_0013587) May Serve As A Novel Biomarker for Pancreatic Cancer. Biomarkers in Medicine 2021; 15(12): 977 doi: 10.2217/bmm-2020-0750
|
| 6 |
Inki Kim, Yeon‐Sook Choi, Jae Hwi Song, Eun A Choi, Sojung Park, Eun Ji Lee, Je‐Keun Rhee, Song Cheol Kim, Suhwan Chang. A drug‐repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6‐thioguanine as an effective therapeutic agent for TPMT‐low cancer cells. Molecular Oncology 2018; 12(9): 1526 doi: 10.1002/1878-0261.12364
|
| 7 |
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami. The CCL20-CCR6 Axis in Cancer Progression. International Journal of Molecular Sciences 2020; 21(15): 5186 doi: 10.3390/ijms21155186
|
| 8 |
Qingqing Wang, Qichao Ni, Xudong Wang, Huijun Zhu, Zhiwei Wang, Jianfei Huang. High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival. Medical Oncology 2015; 32(1) doi: 10.1007/s12032-014-0372-2
|
| 9 |
Massimo Donadelli, Ilaria Dando, Elisa Dalla Pozza, Marta Palmieri. Mitochondrial uncoupling protein 2 and pancreatic cancer: A new potential target therapy. World Journal of Gastroenterology 2015; 21(11): 3232-3238 doi: 10.3748/wjg.v21.i11.3232
|
| 10 |
Gangyin Xie, Linxiao Sun, Yonglin Li, Bicheng Chen, Cheng Wang. Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via AMPK‐mTOR signaling. Cancer Medicine 2021; 10(1): 325 doi: 10.1002/cam4.3611
|
| 11 |
Hui Zhao, Qingqing Wang, Xudong Wang, Huijun Zhu, Shu Zhang, Wei Wang, Zhiwei Wang, Jianfei Huang. Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer. Pancreas 2016; 45(2): 204 doi: 10.1097/MPA.0000000000000453
|
| 12 |
|
| 13 |
Xiangyi He, Jie Zhong, Shuwei Wang, Yufen Zhou, Lei Wang, Yongping Zhang, Yaozong Yuan. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes. Oncotarget 2017; 8(17): 29116 doi: 10.18632/oncotarget.16249
|
| 14 |
Maryam Sharifi, Balal Khalilzadeh, Farzaneh Bayat, Ibrahim Isildak, Habib Tajalli. Application of thermal annealing-assisted gold nanoparticles for ultrasensitive diagnosis of pancreatic cancer using localized surface plasmon resonance. Microchemical Journal 2023; 190: 108698 doi: 10.1016/j.microc.2023.108698
|
| 15 |
Xiangjie Guo, Liqin Zhai, Ruobing Xue, Jieru Shi, Qiang Zeng, Cairong Gao. Mast Cell Tryptase Contributes to Pancreatic Cancer Growth through Promoting Angiogenesis via Activation of Angiopoietin-1. International Journal of Molecular Sciences 2016; 17(6): 834 doi: 10.3390/ijms17060834
|
| 16 |
Deirdré Kruger, Yandiswa Y. Yako, John Devar, Nicola Lahoud, Martin Smith, Surinder K. Batra. Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy. PLOS ONE 2019; 14(8): e0221169 doi: 10.1371/journal.pone.0221169
|
| 17 |
Andréia Vasconcelos-dos-Santos, Rafaela Muniz de Queiroz, Bruno da Costa Rodrigues, Adriane R. Todeschini, Wagner B. Dias. Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression. Journal of Bioenergetics and Biomembranes 2018; 50(3): 175 doi: 10.1007/s10863-017-9740-x
|
| 18 |
Deirdré Kruger, Nicola Lahoud, Yandiswa Y. Yako, John Devar, Martin Smith, Hans A. Kestler. Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease. PLOS ONE 2022; 17(1): e0262439 doi: 10.1371/journal.pone.0262439
|
| 19 |
Laura Kuhlmann, Wiebke M. Nadler, Alexander Kerner, Sabrina A. Hanke, Elisa M. Noll, Christian Eisen, Elisa Espinet, Vanessa Vogel, Andreas Trumpp, Martin R. Sprick, Christoph P. Roesli. Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma. Pancreas 2017; 46(3): 311 doi: 10.1097/MPA.0000000000000743
|
| 20 |
Mona Mohmed Eddfair, Othman Abdulrahman, Omar Alqawi, Mourad Assidi, Abdelbaset Buhmeida, Abdulfattah Elturki, Abdalla Jebriel, Mohamed Elfagieh, Eramah Ermiah. Correlations of demographical and clinicopathological features with patient outcome of pancreatic ductal adenocarcinoma: A retrospective study (2010-2018) from a Libyan Cohort. Journal of Cancer Research and Therapeutics 2023; 19(3): 745 doi: 10.4103/jcrt.jcrt_1778_21
|
| 21 |
Xin Li, Ming Dong, Jianping Zhou, Dehua Zhu, Jinbo Zhao, Weiwei Sheng. C6orf106 accelerates pancreatic cancer cell invasion and proliferation via activating ERK signaling pathway. Molecular and Cellular Biochemistry 2019; 454(1-2): 87 doi: 10.1007/s11010-018-3455-0
|
| 22 |
Chen Chen, Chang Qiang Wu, Tian Wu Chen, Meng Yue Tang, Xiao Ming Zhang. Molecular Imaging with MRI: Potential Application in Pancreatic Cancer. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/624074
|
| 23 |
|
| 24 |
María Victoria García-Ortiz, Pablo Cano-Ramírez, Marta Toledano-Fonseca, María Teresa Cano, Elizabeth Inga-Saavedra, Rosa María Rodríguez-Alonso, Silvia Guil-Luna, María Auxiliadora Gómez-España, Antonio Rodríguez-Ariza, Enrique Aranda. Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer. Clinical Epigenetics 2023; 15(1) doi: 10.1186/s13148-023-01535-4
|
| 25 |
Iván A. González, Liang-I Kang, Gregory A. Williams, Jingxia Liu, David G. DeNardo, William G. Hawkins, Deyali Chatterjee. Tumor-insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual Tumor. American Journal of Surgical Pathology 2020; 44(6): 817 doi: 10.1097/PAS.0000000000001454
|
| 26 |
Melissa L. Brown, Alan Schneyer. A Decade Later: Revisiting the TGFβ Family’s Role in Diabetes. Trends in Endocrinology & Metabolism 2021; 32(1): 36 doi: 10.1016/j.tem.2020.11.006
|
| 27 |
Qun Chen, Wu-Jun Wang, Yun-Xuan Jia, Hao Yuan, Peng-Fei Wu, Wan-Li Ge, Ling-Dong Meng, Xu-Min Huang, Peng Shen, Tao-Yue Yang, Yi Miao, Jing-Jing Zhang, Kui-Rong Jiang. Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review. Cell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00602-8
|
| 28 |
Cecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, Roberta Curto, Claudia Curcio, Valeria Catanzaro, Giuseppe Digilio, Sergio Padovan, Maria Paola Puccinelli, Monica Isabello, Silvio Aime, Paola Cappello, Francesco Novelli. Endogenous glutamine decrease is associated with pancreatic cancer progression. Oncotarget 2017; 8(56): 95361 doi: 10.18632/oncotarget.20545
|
| 29 |
Karen Lacey, James F Bishop, Hannah L Cross, Patty Chondros, Georgios Lyratzopoulos, Jon D Emery. Presentations to general practice before a cancer diagnosis in Victoria: a cross‐sectional survey. Medical Journal of Australia 2016; 205(2): 66 doi: 10.5694/mja15.01169
|
| 30 |
Kezhong Tang, Wenjie Lu, Wenjie Qin, Yulian Wu. Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages. Pancreatology 2016; 16(1): 28 doi: 10.1016/j.pan.2015.11.007
|
| 31 |
Giuseppe Corrias, Sandra Huicochea Castellanos, Ryan Merkow, Russel Langan, Vinod Balachandran, Monica Ragucci, Gabriella Carollo, Marcello Mancini, Luca Saba, Lorenzo Mannelli. Does Second Reader Opinion Affect Patient Management in Pancreatic Ductal Adenocarcinoma?. Academic Radiology 2018; 25(7): 825 doi: 10.1016/j.acra.2017.12.010
|
| 32 |
Chufeng Zhang, Lijie Wang, Yan Guan, Yulan Sun, Xiuju Liu, Dongyuan Zhu, Qisen Guo. Progress of Circulating Tumor Cells in Cancer Management. Technology in Cancer Research & Treatment 2016; 15(3): 509 doi: 10.1177/1533034615583762
|
| 33 |
Neha Parveen, Afsana Sheikh, Mohammed A.S. Abourehab, Ritu Karwasra, Surender Singh, Prashant Kesharwani. Self-nanoemulsifying drug delivery system for pancreatic cancer. European Polymer Journal 2023; 190: 111993 doi: 10.1016/j.eurpolymj.2023.111993
|
| 34 |
Emily A. Probst, Alyson L. Smith, John D. Abad. What is causing this patient's severe pruritus?. JAAPA 2020; 33(6): 54 doi: 10.1097/01.JAA.0000662428.39636.70
|
| 35 |
Hyerim Ahn, Min Song, Go Eun Heo. Inferring Undiscovered Public Knowledge by Using Text Mining Analysis and Main Path Analysis: The Case of the Gene-Protein 'brings_about' Chains of Pancreatic Cancer. Journal of the Korean BIBLIA Society for library and Information Science 2015; 26(1): 217 doi: 10.14699/kbiblia.2015.26.1.217
|
| 36 |
Dana K. Andersen, Murray Korc, Gloria M. Petersen, Guido Eibl, Donghui Li, Michael R. Rickels, Suresh T. Chari, James L. Abbruzzese. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Diabetes 2017; 66(5): 1103 doi: 10.2337/db16-1477
|
| 37 |
Fundamentals of Cancer Detection, Treatment, and Prevention. 2022; : 341 doi: 10.1002/9783527838561.ch15
|
| 38 |
Damiano Caputo, Daniela Pozzi, Tommaso Farolfi, Roberto Passa, Roberto Coppola, Giulio Caracciolo. Nanotechnology and pancreatic cancer management: State of the art and further perspectives. World Journal of Gastrointestinal Oncology 2021; 13(4): 231-237 doi: 10.4251/wjgo.v13.i4.231
|
| 39 |
Cui-Juan Qian, Yi-Yi Chen, Xin Zhang, Fu-Qiang Liu, Ting-Ting Yue, Bei Ye, Jun Yao. Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells. Oncology Letters 2016; 12(5): 3499 doi: 10.3892/ol.2016.5097
|
| 40 |
Li Ji, Chen Gong, Liangyu Ge, Linping Song, Fenfen Chen, Chunjing Jin, Hongyan Zhu, Guoxiong Zhou. Orphan nuclear receptor Nurr1 as a potential novel marker for progression in human pancreatic ductal adenocarcinoma. Experimental and Therapeutic Medicine 2017; 13(2): 551 doi: 10.3892/etm.2016.3968
|
| 41 |
Menazir Sha, Basir Kunduzi, Saied Froghi, Alberto Quaglia, Brian Davidson, Giuseppe K Fusai. Role of circulating exosomal biomarkers and their diagnostic accuracy in pancreatic cancer. JGH Open 2023; 7(1): 30 doi: 10.1002/jgh3.12848
|
| 42 |
Christy E. Cauley, Martha B. Pitman, Jiahua Zhou, James Perkins, Birte Kuleman, Andrew S. Liss, Carlos Fernandez-del Castillo, Andrew L. Warshaw, Keith D. Lillemoe, Sarah P. Thayer. Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings. Journal of the American College of Surgeons 2015; 221(3): 699 doi: 10.1016/j.jamcollsurg.2015.05.014
|
| 43 |
F. Chiellini, D. Puppi, A. M. Piras, A. Morelli, C. Bartoli, C. Migone. Modelling of pancreatic ductal adenocarcinoma in vitro with three-dimensional microstructured hydrogels. RSC Advances 2016; 6(59): 54226 doi: 10.1039/C6RA08420F
|
| 44 |
Jinsheng Ding, Hui Li, Yang Liu, Yongjie Xie, Jie Yu, Huizhi Sun, Di Xiao, Yizhang Zhou, Li Bao, Hongwei Wang, Chuntao Gao. OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.698302
|
| 45 |
Claudia Geismann, Frauke Grohmann, Anita Dreher, Robert Häsler, Philip Rosenstiel, Karen Legler, Charlotte Hauser, Jan Hendrik Egberts, Bence Sipos, Stefan Schreiber, Andreas Linkermann, Zonera Hassan, Günter Schneider, Heiner Schäfer, Alexander Arlt. Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2017; 1864(5): 782 doi: 10.1016/j.bbamcr.2017.02.005
|
| 46 |
Yongping Zhou, Ting Shan, Wenzhou Ding, Zhiyuan Hua, Yijun Shen, Zhihua Lu, Bo Chen, Tu Dai. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo‐YAP signaling. Journal of Cellular Physiology 2018; 233(8): 5805 doi: 10.1002/jcp.26357
|
| 47 |
Jie Xu, Ke‐Qing Shi, Bi‐Cheng Chen, Zhi‐Peng Huang, Fei‐Yu Lu, Meng‐Tao Zhou. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma. Journal of Gastroenterology and Hepatology 2017; 32(7): 1394 doi: 10.1111/jgh.13676
|
| 48 |
Eramah Ermiah, Mona Eddfair, Othman Abdulrahman, Mohamed Elfagieh, Abdalla Jebriel, Mona Al‑Sharif, Mourad Assidi, Abdelbaset Buhmeida. Prognostic value of serum CEA and CA19‑9 levels in pancreatic ductal adenocarcinoma. Molecular and Clinical Oncology 2022; 17(2) doi: 10.3892/mco.2022.2559
|
| 49 |
Meng Guo, Hui Zhao. Growth differentiation factor-15 may be a novel biomarker in pancreatic cancer: A review. Medicine 2024; 103(6): e36594 doi: 10.1097/MD.0000000000036594
|
| 50 |
|
| 51 |
Wansu Chen, Rebecca K. Butler, Eva Lustigova, Suresh T. Chari, Bechien U. Wu. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model in a Diverse and Integrated Healthcare Setting. Digestive Diseases and Sciences 2021; 66(1): 78 doi: 10.1007/s10620-020-06139-z
|
| 52 |
R. Vera, A. Ferrández, C. J. Ferrer, C. Flores, C. Joaquín, S. López, T. Martín, E. Martín, M. Marzo, A. Sarrión, E. Vaquero, A. Zapatero, J. Aparicio. Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies. Clinical and Translational Oncology 2017; 19(7): 834 doi: 10.1007/s12094-016-1609-7
|
| 53 |
Xiao Su, Xiangyi He, Qiwen Ben, Weiyi Wang, Huan Song, Qiao Ye, Yi Zang, Weiguang Li, Ping Chen, Weiyan Yao, Yaozong Yuan. Effect of p53 on pancreatic cancer-glucose tolerance abnormalities by regulating transglutaminase 2 in resistance to glucose metabolic stress. Oncotarget 2017; 8(43): 74299 doi: 10.18632/oncotarget.19402
|